StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) from a hold rating to a buy rating in a research note published on Thursday morning. Other analysts also recently issued reports about the stock. Craig Hallum dropped their price objective on shares of Ironwood Pharmaceuticals from $10.00 to $8.00 and set a “buy” rating […]

StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the stock. Several other research analysts have also weighed in on SYRS. Brookline Capital Management reaffirmed a “hold” rating on shares of Syros Pharmaceuticals in a research note on […]